Kelly Griffis

Kelly Griffis is an experienced professional in clinical operations, currently serving as the Director and Head of Clinical Operations at Iambic Therapeutics since June 2024. Prior to this role, Kelly held the position of Associate Director of Clinical Operations at Day One Biopharmaceuticals from May 2023 to May 2024 and served in similar capacities at Fate Therapeutics Inc from April 2019 to April 2023, where responsibilities included both Associate Director and Senior Clinical Trial Manager. Additionally, Kelly worked as a Clinical Operations Consultant at Capsul Consulting LLC from January 2017 to April 2019 and began a career as a Senior Clinical Research Associate at PPD from September 2012 to October 2016. Kelly holds a Bachelor of Science degree in Cell/Cellular and Molecular Biology from the University of Arizona.